BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18651785)

  • 1. International funding for malaria control in relation to populations at risk of stable Plasmodium falciparum transmission.
    Snow RW; Guerra CA; Mutheu JJ; Hay SI
    PLoS Med; 2008 Jul; 5(7):e142. PubMed ID: 18651785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equity and adequacy of international donor assistance for global malaria control: an analysis of populations at risk and external funding commitments.
    Snow RW; Okiro EA; Gething PW; Atun R; Hay SI
    Lancet; 2010 Oct; 376(9750):1409-16. PubMed ID: 20889199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide.
    Guerra CA; Gikandi PW; Tatem AJ; Noor AM; Smith DL; Hay SI; Snow RW
    PLoS Med; 2008 Feb; 5(2):e38. PubMed ID: 18303939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global fund financing to the 34 malaria-eliminating countries under the new funding model 2014-2017: an analysis of national allocations and regional grants.
    Zelman B; Melgar M; Larson E; Phillips A; Shretta R
    Malar J; 2016 Feb; 15():118. PubMed ID: 26911998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the most efficient allocation of interventions to achieve reductions in Plasmodium falciparum malaria burden and transmission in Africa: a modelling study.
    Walker PG; Griffin JT; Ferguson NM; Ghani AC
    Lancet Glob Health; 2016 Jul; 4(7):e474-84. PubMed ID: 27269393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Funding for malaria control 2006-2010: a comprehensive global assessment.
    Pigott DM; Atun R; Moyes CL; Hay SI; Gething PW
    Malar J; 2012 Jul; 11():246. PubMed ID: 22839432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new world malaria map: Plasmodium falciparum endemicity in 2010.
    Gething PW; Patil AP; Smith DL; Guerra CA; Elyazar IR; Johnston GL; Tatem AJ; Hay SI
    Malar J; 2011 Dec; 10():378. PubMed ID: 22185615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the global clinical burden of Plasmodium falciparum malaria in 2007.
    Hay SI; Okiro EA; Gething PW; Patil AP; Tatem AJ; Guerra CA; Snow RW
    PLoS Med; 2010 Jun; 7(6):e1000290. PubMed ID: 20563310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of eliminating malaria and the impact of the global fund in 34 countries.
    Zelman B; Kiszewski A; Cotter C; Liu J
    PLoS One; 2014; 9(12):e115714. PubMed ID: 25551454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent goals and commitments in global malaria intervention.
    Kiszewski AE
    PLoS Med; 2008 Jul; 5(7):e159. PubMed ID: 18651789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A world malaria map: Plasmodium falciparum endemicity in 2007.
    Hay SI; Guerra CA; Gething PW; Patil AP; Tatem AJ; Noor AM; Kabaria CW; Manh BH; Elyazar IR; Brooker S; Smith DL; Moyeed RA; Snow RW
    PLoS Med; 2009 Mar; 6(3):e1000048. PubMed ID: 19323591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primaquine for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing risk of Plasmodium falciparum malaria infection in Africa: 2000-10: a spatial and temporal analysis of transmission intensity.
    Noor AM; Kinyoki DK; Mundia CW; Kabaria CW; Mutua JW; Alegana VA; Fall IS; Snow RW
    Lancet; 2014 May; 383(9930):1739-47. PubMed ID: 24559537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated global resources needed to attain international malaria control goals.
    Kiszewski A; Johns B; Schapira A; Delacollette C; Crowell V; Tan-Torres T; Ameneshewa B; Teklehaimanot A; Nafo-Traoré F
    Bull World Health Organ; 2007 Aug; 85(8):623-30. PubMed ID: 17768521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The US President's Malaria Initiative, Plasmodium falciparum transmission and mortality: A modelling study.
    Winskill P; Slater HC; Griffin JT; Ghani AC; Walker PGT
    PLoS Med; 2017 Nov; 14(11):e1002448. PubMed ID: 29161259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective analysis on the transmission of Plasmodium falciparum and Plasmodium vivax: the case of Adama City, East Shoa Zone, Oromia, Ethiopia.
    File T; Dinka H; Golassa L
    Malar J; 2019 Jun; 18(1):193. PubMed ID: 31185977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human population, urban settlement patterns and their impact on Plasmodium falciparum malaria endemicity.
    Tatem AJ; Guerra CA; Kabaria CW; Noor AM; Hay SI
    Malar J; 2008 Oct; 7():218. PubMed ID: 18954430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission.
    Torres KJ; Clark EH; Hernandez JN; Soto-Cornejo KE; Gamboa D; Branch OH
    Malar J; 2008 Sep; 7():173. PubMed ID: 18782451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simulation of the cost-effectiveness of malaria vaccines.
    Tediosi F; Maire N; Penny M; Studer A; Smith TA
    Malar J; 2009 Jun; 8():127. PubMed ID: 19505328
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.